Keros Therapeutics (KROS) Other Non-Current Liabilities (2019 - 2021)
Keros Therapeutics (KROS) posted Other Non-Current Liabilities of $16000.0 for Q3 2021, down 50.0% on a QoQ basis from $32000.0 in Q2 2021, and down 79.22% year-over-year from $77000.0 in Q3 2020.
Keros Therapeutics (KROS) Other Non-Current Liabilities (2019 - 2021) Analysis & Trends
Keros Therapeutics' Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $16000.0 for Q3 2021.
- Quarterly Other Non-Current Liabilities fell 79.22% year-over-year to $16000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $16000.0 (down 79.22% YoY) and the FY2020 annual result came in at $62000.0, down 47.9% from the prior year.
- Other Non-Current Liabilities was $16000.0 for Q3 2021 at Keros Therapeutics, down from $32000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $119000.0 in Q4 2019 and bottomed at $16000.0 in Q3 2021.
- A 3-year average of $68500.0 and a median of $69500.0 in 2020 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2020 — Other Non-Current Liabilities slumped 47.9% — and 2021, when it plunged 79.22%.
- Keros Therapeutics' Other Non-Current Liabilities stood at $119000.0 in 2019, then tumbled by 47.9% to $62000.0 in 2020, then plunged by 74.19% to $16000.0 in 2021.
- Business Quant data shows KROS's Other Non-Current Liabilities at $16000.0 in Q3 2021, $32000.0 in Q2 2021, and $47000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Keros Therapeutics | 377.42 Mn | 90.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 16,000.00 |
| Jun 30, 2021 | 32,000.00 |
| Mar 31, 2021 | 47,000.00 |
| Dec 31, 2020 | 62,000.00 |
| Sep 30, 2020 | 77,000.00 |
| Jun 30, 2020 | 91,000.00 |
| Mar 31, 2020 | 104,000.00 |
| Dec 31, 2019 | 119,000.00 |